The Los Angeles Times  recently interviewed Dr. Stanley Chang, Chairman and founder of Medigen BioMedical Group (Medigen), in which he shared the Medigen's  innovative achievements, development strategies, and global expansion plans. The feature has been published in the April 2025 edition of the Los Angeles Times' “Taiwan, Special Report 2025.” For the full interview, please refer to the Los Angeles Times website.